Author:
Lu Yi,Tai Phillip W.L.,Ai Jianzhong,Gessler Dominic J.,Su Qin,Yao Xieyi,Zheng Qiang,Zamore Phillip D.,Xu Xun,Gao Guangping
Funder
The National Key Research and Development Program of China
The National Natural Science Foundation of China
Shanghai Jiaotong University School of Medicine
Chengdu Kanghong Pharmaceutical Group Co., Ltd.
University of Massachusetts Medical School
NIH
Subject
Drug Discovery,Molecular Medicine
Reference34 articles.
1. Corneal blindness: a global perspective;Whitcher;Bull. World Health Organ.,2001
2. Corneal neovascularization: an anti-VEGF therapy review;Chang;Surv. Ophthalmol.,2012
3. The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury;Oh;Stem Cells,2008
4. Novel aspects of corneal angiogenic and lymphangiogenic privilege;Ellenberg;Prog. Retin. Eye Res.,2010
5. Comparison of subconjunctivally injected bevacizumab, ranibizumab, and pegaptanib for inhibition of corneal neovascularization in a rat model;Akar;Int. J. Ophthalmol.,2013
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献